Endothelium-mediated negative dromotropic effects of intravascular acetylcholine

European Journal of Pharmacology

Volumn 362, Issue 2-3, 1998, Pages 157-166

  Ceballos, Guillermo ^a   Rubio, Rafael ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Cardiac control; Endothelial control; Endothelial mediator; Luminal endothelial receptor; Nitric oxide (NO); Parenchymal function; Prostaglandin

Indexed keywords

ACETYLCHOLINE; ARACHIDONIC ACID; DEXTRAN; DITHIOTHREITOL; INDOMETACIN; MUSCARINIC RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXYHEMOGLOBIN; SUPEROXIDE DISMUTASE; TROPANE DERIVATIVE;

ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM; GUINEA PIG; INTRACARDIAC DRUG ADMINISTRATION; ISOLATED HEART; MALE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; VASODILATATION;

ACETYLCHOLINE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTRIC STIMULATION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GUINEA PIGS; HEART; HYDRAZINES; INDOMETHACIN; MALE; MUTAGENS; MYOCARDIUM; NEURAL CONDUCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROGEN OXIDES; OXYHEMOGLOBINS; PROSTAGLANDINS; RECEPTORS, MUSCARINIC; VASODILATOR AGENTS;

EID: 0032408932     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00755-9     Document Type: Article

References (42)

1. Alanis J., Gonzalez H., Lopez E. The electrical activity of the bundle of His. J. Physiol. (Lond.). 142:1958;127-140.
2. Alanis J., Lopez E., Mandoki J. Propagation of impulses through the atrioventricular node. Am. J. Physiol. 197:1959;1171-1174.
3. Amezcua J.L., Dusting G.J., Palmer R.M.J., Moncada S. Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous vasodilator. Br. J. Pharmacol. 95:1988;830-834.
4. Balcells E., Rubio R. Implications of the coronary vascular endothelium as mediator of the vasodilatory and dromotropic actions of adenosine. J. Mol. Cell Cardiol. 25:1993;693-706.
5. Balcells E., Suarez J., Rubio R. Functional role of intravascular coronary endothelial adenosine receptors. Eur. J. Pharmacol. 210:1992;1-9.
6. Balligand J.-L., Kelly R., Marsden P., Smith T., Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA. 9:1993;347-351.
7. Belardinelli, L., West, G.A., Clemo, S.H.F., 1987. Regulation of atrioventricular node function by adenosine. In: Gerlach, E., Becker, B.F. (Eds.), Topics and Perspectives in Adenosine Research. Springer, Berlin, pp. 344-355.
8. Beny J.L. Endothelial and smooth muscle cells hyperpolarized by bradykinin are not dye coupled. Am. J. Physiol. 258:1990;H863-H871. (Heart Circ. Physiol. 27).
9. Bruning T.A., Hendriks M.G.C., Chang P.C., Kuypers E.A.P., Van Zwieten P.A. In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. Circ. Res. 74:1994;912-919.
10. Cauldfield M.P. Muscarinic receptors characterization, coupling and function. Pharmacol. Ther. 58:1993;319-379.
11. Clemo, S.H.F., 1986. Adenosine and AV Conduction. Thesis Dissertation, University of Virginia, Charlottesville.
12. Diamond J., Ten Eick R.E., Trapani A.J. Are increases in cGMP responsible for the negative inotropic effects of acetylcholine in the heart? Biochem. Biophys Res. Comm. 79:1977;912-918.
13. Elvan A., Rubart M., Zipes D. NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. Am. J. Physiol. 272:1997;H263-H271.
14. Endoh M., Maruyama M., Ijima T. Attenuation of muscarinic cholinergic inhibition by islet-activating protein in the heart. Am. J. Physiol. 249:1985;H309-H320.
15. Fink G.D., Paddok R.J., Rodgers G.M., Busuttil R.W., George W.J. Elevated cyclic GMP levels in rabbit atria following vagal stimulation and acetylcholine treatment. Proc. Soc. Exp. Biol. Med. 153:1976;78-82.
16. Frangos J.A., Juchan M.J. Fluid flow activates G-proteins that are coupled to Ca-dependent and independent EDRF production in cultured endothelial cells. FASEB J. 5:1991;A1820. (Abstract).
17. Furchgott R.F., Carvalho M.H., Khan M.T., Matsunaga K. Evidence for endothelium-dependent vasodilation of resistance vessels by acetylcholine. Blood vessels. 24:1987;145-149.
18. George W.J., Polson J.B., O'Toole A.G., Goldberg N.D. Elevation of guanosine 3′-5′-cyclic phosphate in rat heart after perfusion with acetylcholine. Proc. Natl. Acad. Sci. USA. 66:1970;398-403.
19. Goyal R.K. Muscarinic receptor subtypes: physiology and clinical implications. N. Engl. J. Med. 321:1989;1022-1028.
20. 2+ entry in human and bovine endothelial cells. J. Physiol. (Lond.). 482:1995;259-274.
21. Gryglewski R.J., Palmer R.M. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
22. 2+ current in rabbit atrioventricular node cells. Am. J. Physiol. 271:1996;H2274-H2282.
23. Haga K., Haga T. Affinity chromatography of the muscarinic acetylcholine receptor. J. Biol. Chem. 258:1983;13575-13579.
24. Haga K., Haga T. Purification of the muscarinic acetylcholine receptor from porcine brain. J. Biol. Chem. 260:1985;7927-7935.
25. 2+ current in adult rabbit atrioventricular nodal cells. Circ. Res. 78:1996;998-1008.
26. Hancox J.C., Levi A.J., Lee Ch.O., Heap P. A method for isolating rabbit atrioventricular node myocites which retain normal morphology and function. Am. J. Physiol. 265:1993;H755-H766.
27. Hiromasa S., Nishimura M., Tsuji Y., Watanabe Y. Electrophysiologic demonstration of acetylcholine receptors and acetylcholine effects in the rabbit atrioventricular node. J. Am. Cell. Cardiol. 1:1983;730-734.
28. Hulme E.C., Birdsall N.J.M., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
29. Kelm M., Schrader J. Control of coronary vascular tone by nitric oxide. Circ. Res. 66:1990;1561-1575.
30. Komori K., Lorenz R.R., Vanhoutte P.M. Nitric oxide, Ach and electrical and mechanical properties of canine arterial smooth muscle. Am. J. Physiol. 155:1988;H207-H212.
31. Löffelholz K., Pappano A.J. The parasympathetic neuroeffector junction in the heart. Pharmacol. Rev. 37:1985;1-24.
32. Marangos J.P. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. J. Med. Chem. 34:1991;3242-3251.
33. Martin W., Villani M., Jothianandan D., Furchgott R.F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 233:1985;679-685.
34. Metsa-Ketela T., Kuosa R., Vapaatalo H. Temporal dissociation between negative inotropism and the increase in cGMP level induce by choline esters in spontaneously beating rat atria preparations. Acta Physiol. Scand. 110:1980;83-87.
35. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ. Res. 82:1998;204-209.
36. Parkington H.C., Tare M., Coleman H.A. More than one agent is involved in the hyperpolarization induced by acetylcholine in coronary arteries of guinea pigs. Blood Vessels. 27:1990;52-57.
37. Rees D.D., Palmer R.M., Hodson H.F., Moncada S. Specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol. 96:1989;418-424.
38. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactive endothelium-derived relaxing factor. Am. J. Physiol. 250:1986;H822-H827.
39. Rubio R., Ceballos G., Suarez J. Coronary flow stimulates auricular-ventricular transmission in the isolated perfused guinea pig heart. Am. J. Physiol. 26:1995;H1177-H1185.
40. Tare M., Parkington H.C., Coleman H.A., Neild T., Dusting G.J. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 346:1990;69-71.
41. Taylor, A.E., Granger, D.N., 1984. Exchange of macromolecules across the microcirculation. In: Renkin, E.M., Michel, C.C., Geiger, S.R. (Eds.), Handbook of Physiology, Section 2, The Cardiovascular System, Vol. 4, Microcirculation, Part 1. Am. Phys. Soc., Bethesda, pp. 488-510.
42. Wahler G.M., Sperelakis N. Intracellular injection of cyclic GMP depresses cardiac slow action-potentials. J. Cyclic Nucleotide Prot. Res. 10:1985;83-95.